Clarke Barlow
Founder chez AMG ACQUISITION CORP.
Fortune : 15 467 $ au 30/04/2024
Profil
Clarke Barlow is the founder of AMG Acquisition Corp., which was founded in 2021.
He is currently the Director at Neuroscientific Biopharmaceuticals Ltd.
since 2023, Non-Executive Director at Tryptamine Therapeutics Ltd.
since 2024, and a Member at the Australian Institute of Co. Directors.
He previously served as a Non-Executive Director at Exopharm Ltd.
Mr. Barlow completed his undergraduate degree at The University of Western Australia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AMG ACQUISITION CORP.
6,84% | 27/04/2023 | 533 340 ( 6,84% ) | 15 467 $ | 30/04/2024 |
Postes actifs de Clarke Barlow
| Sociétés | Poste | Début |
|---|---|---|
| AMG ACQUISITION CORP. | Founder | 01/06/2021 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Director/Board Member | 17/11/2023 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Anciens postes connus de Clarke Barlow
| Sociétés | Poste | Fin |
|---|---|---|
| EXOPHARM | Director/Board Member | - |
Formation de Clarke Barlow
| The University of Western Australia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
| AMG Acquisition Corp. |
